RSS Feeds
Search

Press releases

Press releases

Displaying 1..2 of 2 - per page
Order by
GenMont probiotics products receive China market entry approval
Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
Medigreen announces MAF, a new botanical-based anti-allergy formulation
At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Allergy Therapy Area Pipeline Report
Nov 2010 - 1517 pages - $1,495
Grass Pollen Allergy - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
Allergy Therapeutics plc – Product Pipeline Review – Q4 2010
Dec 2010 - 48 pages - $500
Birch Pollen Allergy - Pipeline Review, Q2 2011
May 2011 - 39 pages - $500
Enjoy Life Natural Brands Case Study: capitalizing on rising consumer interest in anti-allergy foods
Aug 2009 - 11 pages - $295
Allergy Research Group, Inc.-Detailed Product Pipeline
Jul 2010 - 180 pages - $750
Allergy Therapeutics plc (AGY) - Financial and Strategic SWOT Analysis Review
May 2011 - 35 pages - $125
Allergy Therapeutics plc (AGY) - Financial and Strategic SWOT Analysis Review
Feb 2011 - 28 pages - $125
Allergy Therapeutics-Therapeutic Competitors Report
Nov 2010 - 37 pages - $600
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us